Knowing What You Don’t Know: Utilizing Medical Affairs to Facilitate Patient-Centric Drug Development

Time: 4:30 pm
day: Day Two


  • Developing medical affairs teams to enter into new therapeutic areas
  • Benefits of patient engagement early in the development process
  • Bringing an epigenetic therapy into a gene therapy treatment landscape